BlackRock Portfolio holdings
BlackRock is an asset manager that runs the iShares family of exchange-traded funds. It was founded in 1988 by Larry Fink, a mortgage-bond pioneer at First Boston, and several colleagues, to manage money for institutions with a focus on risk. Blackstone backed the start-up in exchange for a stake in its bond business, and the two parted ways in 1994. BlackRock went public in 1999 and merged with the investment managers division of Merrill in 2006. BlackRock bought the iShares business from Barclays in 2010 and the private credit manager HPS Investment Partners in 2025. It also sells technology: its Aladdin platform gives institutional investors tools for portfolio management, risk analysis, trading and accounting, and its BlackRock Solutions unit, launched in 2000, advises on risk management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$8.67B |
| 2 |
Microsoft
MSFT
|
+$5.68B |
| 3 |
HONA
Honeywell Aerospace
HONA
|
+$5.24B |
| 4 |
Apple
AAPL
|
+$5.23B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$5.04B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$5.81B |
| 2 |
Coterra Energy
CTRA
|
+$2.24B |
| 3 |
Intel
INTC
|
+$2.13B |
| 4 |
Qualcomm
QCOM
|
+$2.03B |
| 5 |
Hologic
HOLX
|
+$1.7B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.75% |
| 2 | Financials | 11.04% |
| 3 | Industrials | 9.81% |
| 4 | Healthcare | 9.52% |
| 5 | Consumer Discretionary | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4576
Vanguard S&P Small-Cap 600 Value ETF
VIOV
$1.85B
| $235K | ﹤0.01% |
2,000
| – | – |
2026 Q1
1 quarter
|
|
4577
Cytosorbents Corp
CTSO
$18.4M
| $235K | ﹤0.01% |
31,361
-7,789
| -20% | -$82.3K |
2016 Q3
39 quarters
|
|
4578
Central Plains Bancshares
CPBI
$80.9M
| $234K | ﹤0.01% |
12,276
+3,118
| +34% | +$56.2K |
2023 Q4
10 quarters
|
|
4579
RAVE Restaurant Group
RAVE
$29.8M
| $233K | ﹤0.01% |
71,198
+15,178
| +27% | +$43.1K |
2017 Q1
37 quarters
|
|
4580
Invesco S&P 500 Pure Value ETF
RPV
$1.8B
| $232K | ﹤0.01% |
2,041
+1,675
| +458% | +$187K |
2024 Q4
6 quarters
|
|
4581
Myomo
MYO
$50.3M
| $232K | ﹤0.01% |
223,217
-1,465,173
| -87% | -$1.43M |
2021 Q2
20 quarters
|
|
4582
MIRA Pharmaceuticals
MIRA
$26M
| $232K | ﹤0.01% |
244,622
+132,276
| +118% | +$134K |
2025 Q3
3 quarters
|
|
4583
ImmuCell
ICCC
$92.8M
| $230K | ﹤0.01% |
22,860
+4,674
| +26% | +$41.3K |
2017 Q1
37 quarters
|
|
4584
Lipocine
LPCN
$19M
| $229K | ﹤0.01% |
89,272
| – | – |
2016 Q2
40 quarters
|
|
4585
Uranium Royalty Corp
UROY
$1.13B
| $227K | ﹤0.01% |
81,822
| – | – |
2025 Q4
2 quarters
|
|
4586
374Water
SCWO
$41.1M
| $227K | ﹤0.01% |
119,519
+40,227
| +51% | +$102K |
2023 Q1
13 quarters
|
|
4587
Firefly Neuroscience
AIFF
$14.9M
| $226K | ﹤0.01% |
187,168
+17,806
| +11% | +$31K |
2025 Q2
4 quarters
|
|
4588
Edesa Biotech
EDSA
$24M
| $224K | ﹤0.01% |
27,495
-214
| -0.8% | -$1.93K |
2026 Q1
1 quarter
|
|
4589
iShares US Healthcare Providers ETF
IHF
$1.5B
| $223K | ﹤0.01% |
4,039
| – | – |
2024 Q3
7 quarters
|
|
4590
Urban One Class D
UONEK
$15M
| $223K | ﹤0.01% |
48,279
| – | – |
2016 Q2
40 quarters
|
|
4591
DELISTED
NSTS Bancorp
NSTS
| $223K | ﹤0.01% |
16,171
+4,010
| +33% | +$52.6K |
2022 Q1
17 quarters
|
|
4592
Kalaris Therapeutics
KLRS
$54.8M
| $222K | ﹤0.01% |
54,442
+18,399
| +51% | +$95.6K |
2020 Q3
23 quarters
|
|
4593
Boundless Bio
BOLD
$57M
| $221K | ﹤0.01% |
88,495
+17,820
| +25% | +$27.4K |
2024 Q1
9 quarters
|
|
4594
Invesco Dividend Achievers ETF
PFM
$820M
| $221K | ﹤0.01% |
3,978
| – | – |
2025 Q4
2 quarters
|
|
4595
Astrotech Corp
ASTC
$9.07M
| $220K | ﹤0.01% |
20,188
| – | – |
2017 Q1
37 quarters
|
|
4596
NanoViricides
NNVC
$36.3M
| $219K | ﹤0.01% |
158,753
+1
| +0% | +$1 |
2017 Q1
37 quarters
|
|
4597
OptimumBank Holdings
OPHC
$113M
| $219K | ﹤0.01% |
37,458
+12,731
| +51% | +$70.1K |
2024 Q2
8 quarters
|
|
4598
iShares Emerging Markets Equity Factor ETF
EMGF
$1.88B
| $216K | ﹤0.01% |
2,954
-23
| -0.8% | -$1.61K |
2021 Q3
19 quarters
|
|
4599
First Trust Dorsey Wright Focus 5 ETF
FV
$3.74B
| $216K | ﹤0.01% |
2,841
| – | – |
2025 Q4
2 quarters
|
|
4600
First Trust Large Cap Value AlphaDEX Fund
FTA
$1.47B
| $215K | ﹤0.01% |
2,217
| – | – |
2026 Q1
1 quarter
|
|
Similar funds
BlackRock's Q2 2026 Portfolio in Review
As of Q2 2026, BlackRock held 5,933 positions worth $6.73T, up 18% from $5.72T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BlackRock's Q2 2026 filing shows 244 new, 3,464 increased, 1,293 reduced and 235 closed positions. Its largest new stake was SpaceX: 51,037,137 shares worth $8.72B. The largest sale was Honeywell, an estimated $5.81B.
By sector, the portfolio is most concentrated in Technology at 35% of assets, up from 30% a quarter earlier, followed by Financials and Industrials.
- BlackRock's largest Q2 2026 buy was SpaceX: 51,037,137 shares worth $8.72B.
- BlackRock added most to Microsoft in Q2 2026, an estimated $5.68B increase.
- BlackRock's biggest Q2 2026 reduction was Honeywell, cutting an estimated $5.81B.
- BlackRock fully exited Coterra Energy in Q2 2026, selling an estimated $2.24B.
- BlackRock's ten largest holdings make up 28% of its $6.73T portfolio in Q2 2026.
- BlackRock opened 244 new positions and closed 235 in Q2 2026.
- BlackRock's portfolio value rose 18% quarter-over-quarter to $6.73T.
Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.